New York S 6967: Directs the commissioner of health to promulgate rules and regulations to reduce the diversion of addiction medications

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S06967 Summary:

BILL NOS06967 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORLANZA

&nbsp

COSPNSRROLISON

&nbsp

MLTSPNSR

&nbsp

Add §3309-c, Pub Health L

&nbsp

Directs the commissioner of the department of health to promulgate rules and regulations promoting recovery from opioid misuse and reducing diversion of addiction medicines.

Go to top S06967 Actions:

BILL NOS06967 

&nbsp

03/27/2025REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS

01/07/2026REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS

Go to topS06967 Committee&nbspVotes:

Go to topS06967 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS06967 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 6967

 2025-2026 Regular Sessions

 IN SENATE

 March 27, 2025
 ___________

 Introduced by Sens. LANZA, ROLISON -- read twice and ordered printed,
 and when printed to be committed to the Committee on Alcoholism and
 Substance Use Disorders

 AN ACT to amend the public health law, in relation to directing the
 commissioner of the department of health to promulgate rules and regu-
 lations promoting recovery from opioid misuse and reducing diversion
 of addiction medicines

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The public health law is amended by adding a new section
 2 3309-c to read as follows:
 3 § 3309-c. Promoting recovery from opioid misuse and reducing diversion
 4 of addiction medicines. 1. The commissioner shall, in consultation with
 5 the office of addiction services and supports, promulgate rules and
 6 regulations pertaining to individual physicians and group practices
 7 including, but not limited to, physician's office-based opioid treat-
 8 ment, opioid treatment programs and any other treatment practices serv-
 9 ing more than fifty patients at a time who have a primary or secondary
 10 diagnosis of opiate misuse or addiction. Such rules and regulations
 11 shall at a minimum include the following provisions:
 12 (a) All patients seeking treatment for opiate use disorder shall be
 13 given an orientation including factual information and an easily under-
 14 stood explanation of each addiction medication option approved by the
 15 United States food and drug administration. Such education must be docu-
 16 mented in the patient record along with documentation regarding the
 17 patient's choice of one of the medication options or none of them. Such
 18 documentation shall be signed by the patient, or the commissioner may
 19 specify some other form of documentation showing that the medical
 20 provider made a good faith effort to obtain such informed consent from
 21 the patient;

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD11099-01-5

 S. 6967 2

 1 (b) If a patient chooses an addiction medication not available through
 2 the medical practitioner, such practitioner must make a referral to a
 3 treatment setting where the patient can access such patient's preferred
 4 medication option;
 5 (c) The medical provider shall utilize the level of care for alcohol
 6 and drug treatment referral web application provided by the office of
 7 addiction services and supports or another patient assessment instrument
 8 approved by the office of addiction services and supports to help deter-
 9 mine an appropriate level of patient care;
 10 (d) In the event that the patient using opiates declines to engage in
 11 treatment the medical provider shall provide such patient with informa-
 12 tion about accessible harm reduction services;
 13 (e) Treatment counseling shall be provided to all individuals for whom
 14 an addiction medication is prescribed or dispensed. Such treatment coun-
 15 seling may be provided by a qualified addiction professional, as deter-
 16 mined by the office of addiction services and supports, employed by the
 17 medical practice or through a contract with an office of addiction
 18 services and supports certified treatment program;
 19 (f) The medical provider shall develop a treatment plan for each
 20 patient and such plan shall be reviewed, at a minimum, every six months.
 21 The standards for developing individual treatment plans shall be det